Calumet, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Calumet, Inc. (CLMT) on May 13, 2025. The report addresses Item 8.01 (Other Events) regarding the termination of a Rule 10b5-1 trading plan by Stephen Mawer, Chair of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance and insider trading disclosures.
Material Changes
The primary material event is the termination of a pre-arranged stock sale plan:
- Plan Termination: On May 13, 2025, Stephen Mawer terminated a Rule 10b5-1 trading plan originally adopted on November 15, 2024.
- Plan Scope: The plan, which commenced on March 6, 2025, allowed for the potential sale of up to 40,205 shares of common stock.
- Execution Status: Prior to termination, 10,965 shares of common stock were sold under the plan.
Guidance, Outlook, and Risks
The filing contains no management commentary on financial guidance, outlook, or operational risks. The disclosure is strictly procedural regarding the insider trading plan.
Key Facts for Investor Verification
- Verify the total number of shares sold by Stephen Mawer under the terminated plan (10,965 shares).
- Confirm the remaining unsold shares under the plan (29,240 shares) are no longer subject to the trading schedule.
- Review the timing of the sales to ensure compliance with the plan's commencement date of March 6, 2025.